Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 30 for “"colorectal carcinoma"”.
-
Hereditary non-polyposis colorectal carcinoma (HNPCC) : morphological and immunohistochemical studies
Families with hereditary non-polyposis colorectal carcinoma (HNPCC) are not uncommon along the West-Coast of South Africa. These patients present with early onset carcinomas mostly colorectal, predominantly in the right colon. They may develop tumours of other organs, including uterus, breast, …
-
Assessing the Role of Dietary Polyamines on the Continuum of Colorectal Carcinoma
… ~70% efficacy in preventing premalignant colorectal adenomas (CRA) in a clinical trial; however, high polyamine intakes mitigated this preventative action. Further, dietary polyamines increase the dysplasia of CRA in initiated animal models of colorectal cancer (CRC) and are hypothesized …
-
Detection of colorectal carcinoma-associated antigens using specific antibodies against human milk oligosaccharides
… homologous haptens as gangliosides in the human colorectal carcinoma cell line SW'lll6. Sialyltetrasaccharide b-ceramide was detected in the monosialylganglioside fraction from human meconium and a total ganglioside fraction from SWlll6 cells on thin layer chromatograms by radioimmune staining …
-
Structural analysis of glycolipid-derived oligosaccharides from metabolically radiolabelled colorectal carcinoma SW1116 cells
… carbohydrate portion of glycosphingolipids from colorectal carcinoma cells, SW1116, by metabolically labelling the cells with radioactive monosaccharide precursors. SW1116 cells (1 x 10⁶) metabolically labelled with 222 μCi/ml of either 6-[³H]-D-galactose (25 Ci/mMol) or 6-[³H]-D-glucosamine (38 …
-
Novel Oligomeric Fluoropyrimidines and Their Efficacy for the Treatment of Colorectal Carcinoma Independent of p53 Mutation
The treatment of advanced stage colorectal carcinoma (CRC) is rarely achieved with today’s standard of care, including 5-fluorouracil (5-FU). Resistance to 5-FU is unfortunately frequent in CRC partially due to the dependency 5-FU displays towards normal p53 function, a tumor suppressor protein …
-
Expression of Markers for Autophagy and Necroptosis in Colorectal Carcinoma // Експресия на маркери за автофагия и некроптоза при дебелочревен карцином
Колоректалният карцином (КРК) е злокачествено заболяване, чиято честота в последните години непрекъснато нараства. През последните години бяха разработени редица обещаващи туморни маркери, допринасящи за ранното диагностициране, прогностична оценка и мониториране на заболяването. При пациенти с КРК …
-
The histopathology and immunohistochemical expression of cell cycle regulators and mismatch repair gene proteins in colorectal carcinoma : a comparative study
Introduction: It has been reported that HNPCC colorectal carcinomas demonstrate a better prognosis compared to sporadic carcinoma, however the exact mechanism for this is still uncertain. It is possible that tumour morphology, location and cell cycle markers may be indicators of the underlying …
-
Investigating the clinicopathological spectrum and associated genetics of colorectal carcinoma in young (<60 years of age) patients in the Western Cape Province
The incidence of colorectal carcinoma (CRC) in young patients is rising in sub-Saharan Africa, and is set to become a major public health problem within the next decade. Despite this, there is a paucity of large-scale genomic studies in the subregion. To investigate driver genes, oncogenic …
-
Pre-operative determination of Carcinoembryonic Antigen (p-CEA) as an independent prognostic factor of Disease Free Survival (DFS) in patients treated for colorectal carcinoma
… un gruppo di pazienti trattati radicalmente per carcinoma colorettale, se la determinazione dell’antigene carcinoembrionario (p-CEA) possa avere una valenza prognostica e costituire un fattore di rischio indipendente in relazione al disease free survival. BACKGROUND: Il p-CEA sembra essere …
-
Regulatory Mechanisms of Mitotic Catastrophe Induced by Doxorubicin
… mechanisms of mitotic catastrophe in human colorectal carcinoma cells. MATERIALS AND METHODS: We used human hepatoma (Huh-7) and human hepatocellular carcinoma cell lines (SNU-354, -398, -449, and -475) to distinguish the mode of low doses (LD) of doxorubicin-induced cell death from that of …
-
Decoding Copy Number Substructure and Evolution From Single Cell Genomics
… the liver and pleural effusion and two matched colorectal carcinoma and its matched metastatic tumors.</p>
-
Part I: Evaluation Of Russian Synthetic Compounds As A Potential Source Of New Drug Leads Agains Breast And Colon Cancer Part Ii: Isolation Of Beta-amyrin Formate From Eucalyptus Viminalis Labill And Investigation Of Its Colon Cancer Activity
… two types of cancer: human breast SK-Br-3 and colorectal carcinoma HT-29. The bioassay results show that seven of the new synthetic Russian compounds can be considered new drug leads, based upon their low toxicity and efficacy in slowing the growth of human breast cancer and colon cancer cells. …
-
A novel genomic approach to multiple cancer diagnostics using mutations in blood bound EV RNA: Machine Learning Methods For Biomarker Detection and Protein Mutation Assessment
… of cancers such as pancreatic ductal adenocarcinoma (PDAC), which is often diagnosed in later stages. Extracellular vesicles (EVs) released into the blood from tumour cells make good biomarkers for this purpose by protecting their nucleotide cargo from the harsh environment, reflecting the …
-
Investigating the molecular dynamics of gene re-silencing following treatment with epigenetic therapies
… exposure, a model gene (MLH1) and cell line (the colorectal carcinoma cell line RKO) were identified and validated. Gene reactivation was dependent on DNMT1 depletion and hypomethylation, nucleosome eviction and the acquisition of active histone marks at the MLH1 promoter. However, close …
-
Metabolic Manipulation of Glutathione as an Anticancer Therapeutic Target
… seemingly dictated cell fate, whereby HT29 colorectal carcinoma cells displayed decreased cell survival, increased H2O2 and decreased glutathione. CCD 841 normal colon cells were insensitive to palmitoylcarnitine despite increased H2O2, yet maintained glutathione. HepG2 hepatocarcinoma …
-
The Role Of ROS-mediated ERK and JNK Activation In The Induction Of Autophagy And Apoptosis In Tumour Cells By A Novel Small Molecule Compound
… autophagy and apoptotic cell death in human colorectal carcinoma cells. It was later discovered that the ability of C1 to induce autophagy is not limited to a single cell line. Of importance, this study supported the existence of non-canonical autophagy induced by C1. Whereas, silencing of …
-
Targeted Drug Delivery with Cyclodextrin-based Nanocarriers and Focused Ultrasound Triggering
… treatments to 4 live mice bearing tumours (human colorectal carcinoma, up to 1059.71 mm3) under anaesthesia with full recovery.<br/>Conclusions: The study demonstrated the possibility of translation of the constructed ?-CD derivative to potential clinical use as a delivery vehicle for DOX using …
-
Genomic analysis in human solid tumours:Copper Homeostasis Genes in Colorectal cancer
… mutations in copper homeostasis genes (CHGs) in colorectal cancer, and such analysis, performed on 228 colorectal tumor samples, has revealed that inactivating mutations are extremely rare in CHGs. 2. The collection of whole transcriptome profiles by oligonucleotide microarrays represents the …
-
The healthy effects of L. barbarum on in vitro cell models
… such as malignant melanoma, renal cell carcinoma, colorectal carcinoma, and lung cancer. Besides the great variety of association studies, there is a need of studies to unravel its therapeutic effects at the biochemical level. In our study, we demonstrate that Goji dry extracts do not …
-
The Treatment of Solid Tumours with Complete Freund's Adjuvant
… not, however, found to be effective in the CT26 colorectal carcinoma and the DEN-induced Hepatocellular carcinoma. Combination therapy with CFA and anti-CTLA-4, which blocks the inhibitory effects of CTLA-4 on T cells, did not improve CFA treatment efficacy in either the P815 or 4T1 models, but …
Page 1 of 2